Pankreas Kanserinde Hedefsel Nanopartikül Tedavisi ve Klinik Denemeler

Abstract

Chemotherapeutic agents clinically used in pancreatic cancer, which is one of the cancer types with the highest mortality, are inadequate to extent the survival and eliminate the lethal effects. Several chemotherapeutic agents combined with proteins such as albumin were obtained to increase the survival time THE NANOPARTICLE-BASED TARGETED THERAPHY FOR PANCREATIC CANCER AND CLINICAL TRIALS